135 related articles for article (PubMed ID: 10814514)
41. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
42. 6-phosphofructokinase from Pichia pastoris: purification, kinetic and molecular characterization of the enzyme.
Kirchberger J; Bär J; Schellenberger W; Dihazi H; Kopperschläger G
Yeast; 2002 Aug; 19(11):933-47. PubMed ID: 12125050
[TBL] [Abstract][Full Text] [Related]
43. Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.
Durante P; Raleigh X; Gómez ME; Campos G; Ryder E
Biochem Biophys Res Commun; 1996 Aug; 225(3):975-82. PubMed ID: 8780720
[TBL] [Abstract][Full Text] [Related]
44. Role of Ser530, Arg292, and His662 in the allosteric behavior of rabbit muscle phosphofructokinase.
Chang SH; Kemp RG
Biochem Biophys Res Commun; 2002 Jan; 290(2):670-5. PubMed ID: 11785951
[TBL] [Abstract][Full Text] [Related]
45. Structure and expression of the cDNA for the C isozyme of phosphofructo-1-kinase from rabbit brain.
Li Y; Valaitis AP; Latshaw SP; Kwiatkowska D; Tripathi RL; Campbell MC; Kemp RG
J Biol Chem; 1994 Feb; 269(8):5781-7. PubMed ID: 8119919
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.
Vora S; Giger U; Turchen S; Harvey JW
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8109-13. PubMed ID: 2933748
[TBL] [Abstract][Full Text] [Related]
47. Phosphofructokinase from Plasmodium berghei: a kinetic model of allosteric regulation.
Buckwitz D; Jacobasch G; Gerth C
Mol Biochem Parasitol; 1990 May; 40(2):225-32. PubMed ID: 2141917
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a new liver- and kidney-specific pfkfb3 isozyme that is downregulated by cell proliferation and dedifferentiation.
Duran J; Gómez M; Navarro-Sabate A; Riera-Sans L; Obach M; Manzano A; Perales JC; Bartrons R
Biochem Biophys Res Commun; 2008 Mar; 367(4):748-54. PubMed ID: 18191036
[TBL] [Abstract][Full Text] [Related]
49. Genetic reprogramming of lactate dehydrogenase, citrate synthase, and phosphofructokinase mRNA in bovine nuclear transfer embryos produced using bovine fibroblast cell nuclei.
Winger QA; Hill JR; Shin T; Watson AJ; Kraemer DC; Westhusin ME
Mol Reprod Dev; 2000 Aug; 56(4):458-64. PubMed ID: 10911395
[TBL] [Abstract][Full Text] [Related]
50. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity.
Spitz GA; Furtado CM; Sola-Penna M; Zancan P
Biochem Pharmacol; 2009 Jan; 77(1):46-53. PubMed ID: 18851958
[TBL] [Abstract][Full Text] [Related]
51. Phosphofructokinases from Escherichia coli. Purification and characterization of the nonallosteric isozyme.
Babul J
J Biol Chem; 1978 Jun; 253(12):4350-5. PubMed ID: 149128
[TBL] [Abstract][Full Text] [Related]
52. Identification of allosteric sites in rabbit phosphofructo-1-kinase.
Li Y; Rivera D; Ru W; Gunasekera D; Kemp RG
Biochemistry; 1999 Dec; 38(49):16407-12. PubMed ID: 10587466
[TBL] [Abstract][Full Text] [Related]
53. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
54. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
56. Designing an allosterically locked phosphofructokinase.
Kundrot CE; Evans PR
Biochemistry; 1991 Feb; 30(6):1478-84. PubMed ID: 1825177
[TBL] [Abstract][Full Text] [Related]
57. Effect of the cancer specific shorter form of human 6-phosphofructo-1-kinase on the metabolism of the yeast Saccharomyces cerevisiae.
Andrejc D; Možir A; Legiša M
BMC Biotechnol; 2017 May; 17(1):41. PubMed ID: 28482870
[TBL] [Abstract][Full Text] [Related]
58. The phosphofructokinase-uncharged tRNA interaction in metabolic and cell cycle control: an interpretive review.
Rabinovitz M
Nucleic Acids Symp Ser; 1995; (33):182-9. PubMed ID: 8643365
[TBL] [Abstract][Full Text] [Related]
59. Expression of key substrate cycle enzymes in rat spermatogenic cells: fructose 1,6 bisphosphatase and 6 phosphofructose 1-kinase.
Yáñez AJ; Bustamante X; Bertinat R; Werner E; Rauch MC; Concha II; Reyes JG; Slebe JC
J Cell Physiol; 2007 Sep; 212(3):807-16. PubMed ID: 17492776
[TBL] [Abstract][Full Text] [Related]
60. ATP and fructose-2,6-bisphosphate regulate skeletal muscle 6-phosphofructo-1-kinase by altering its quaternary structure.
Zancan P; Marinho-Carvalho MM; Faber-Barata J; Dellias JM; Sola-Penna M
IUBMB Life; 2008 Aug; 60(8):526-33. PubMed ID: 18465796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
